Groww, Alkem Labs, Gallant Ispat shares see Rs 2,334 crore worth block deals; stocks react

Groww, Alkem Labs, Gallant Ispat shares see Rs 2,334 crore worth block deals; stocks react

Data showed that 8.7 crore shares of Groww changed hands at Rs 219 apiece, aggregating Rs 1,905.30 crore. The transaction price was at a 2.63 per cent discount to Monday's closing price of Rs 224.92 apiece.

Advertisement
    Share:
Alkem Laboratories saw 5.98 lakh shares change hands at Rs 5,050 apiece, aggregating Rs 301.90 crore.Alkem Laboratories saw 5.98 lakh shares change hands at Rs 5,050 apiece, aggregating Rs 301.90 crore.
Amit Mudgill
  • Nov 17, 2026,
  • Updated Nov 17, 2026 9:28 AM IST

Billionbrains Garage Ventures Ltd, Alkem Laboratories Ltd and Gallantt Ispat Ltd witnessed block deals worth a combined Rs 2,334 crore on the NSE on Tuesday. Data showed that 8.7 crore shares of Groww changed hands at Rs 219 apiece, aggregating Rs 1,905.30 crore. The transaction price was at a 2.63 per cent discount to Monday's closing price of Rs 224.92 apiece. The shares accounted for 1.4 per cent of Groww's total equity.

Advertisement

Alkem Laboratories saw 5.98 lakh shares change hands at Rs 5,050 apiece, aggregating Rs 301.90 crore. Groww shares were trading 0.68 per cent higher at Rs 226 apiece. Alchem Labs rose 0.37 per cent to Rs 5,144.50. Gallant Ispat shares were down 1.68 per cent at Rs 533. 

In the case of Alkem Labs, Nirmal Bang on November 13 noted that branded formulations grew 12.1 per cent in Q2, led by chronic therapies, while trade generics remained subdued amid competition and tighter credit. It said US growth remained under pressure, with Volume growth of 10 per cent largely offset by 16 per cent price erosion in a single product, highlighting continued pricing vulnerability.

In the case of Groww, it reported Q2 strong revenue growth, driven by rising product adoption by users. Its brokerage business is gaining market share across segments, with its newer products, MTF and commodities, aggressively fueling further growth, MOFSL said in an October note. 

Advertisement

"The scale, coupled with strong operational efficiency, has also driven robust profitability growth during the quarter. We expect overall order volumes in the broking segment to report 20 per cent growth over FY27-28, backed by market share gains, with revenue growth further supported by improving revenue per order. Continued expansion in the MTF segment, along with gradual growth in LAS and wealth management, is expected to provide an additional boost to top-line growth," it said. 

Disclaimer: Business Today provides stock market news for informational purposes only and should not be construed as investment advice. Readers are encouraged to consult with a qualified financial advisor before making any investment decisions.

Billionbrains Garage Ventures Ltd, Alkem Laboratories Ltd and Gallantt Ispat Ltd witnessed block deals worth a combined Rs 2,334 crore on the NSE on Tuesday. Data showed that 8.7 crore shares of Groww changed hands at Rs 219 apiece, aggregating Rs 1,905.30 crore. The transaction price was at a 2.63 per cent discount to Monday's closing price of Rs 224.92 apiece. The shares accounted for 1.4 per cent of Groww's total equity.

Advertisement

Alkem Laboratories saw 5.98 lakh shares change hands at Rs 5,050 apiece, aggregating Rs 301.90 crore. Groww shares were trading 0.68 per cent higher at Rs 226 apiece. Alchem Labs rose 0.37 per cent to Rs 5,144.50. Gallant Ispat shares were down 1.68 per cent at Rs 533. 

In the case of Alkem Labs, Nirmal Bang on November 13 noted that branded formulations grew 12.1 per cent in Q2, led by chronic therapies, while trade generics remained subdued amid competition and tighter credit. It said US growth remained under pressure, with Volume growth of 10 per cent largely offset by 16 per cent price erosion in a single product, highlighting continued pricing vulnerability.

In the case of Groww, it reported Q2 strong revenue growth, driven by rising product adoption by users. Its brokerage business is gaining market share across segments, with its newer products, MTF and commodities, aggressively fueling further growth, MOFSL said in an October note. 

Advertisement

"The scale, coupled with strong operational efficiency, has also driven robust profitability growth during the quarter. We expect overall order volumes in the broking segment to report 20 per cent growth over FY27-28, backed by market share gains, with revenue growth further supported by improving revenue per order. Continued expansion in the MTF segment, along with gradual growth in LAS and wealth management, is expected to provide an additional boost to top-line growth," it said. 

Disclaimer: Business Today provides stock market news for informational purposes only and should not be construed as investment advice. Readers are encouraged to consult with a qualified financial advisor before making any investment decisions.
Read more!
Advertisement